CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Common Stock Pre-Funded Warrants	Additional Paid-In Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		21,005,405
Beginning balance at Dec. 31, 2022	$ 4,851	$ 2		$ 184,753	$ (179,904)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and common stock warrants, net of issuance costs (in shares)		7,220,217
Issuance of common stock and common stock warrants, net of issuance costs	18,554	$ 1		18,553
Issuance of common stock, net of issuance costs (in shares)		76,882
Issuance of common stock, net of issuance costs	268			268
Issuance of common stock under employee stock purchase plan (in shares)		91,454
Issuance of common stock under employee stock purchase plan	107			107
Stock-based compensation	1,597			1,597
Net loss	(29,204)				(29,204)
Ending balance (in shares) at Sep. 30, 2023		28,393,958
Ending balance at Sep. 30, 2023	(3,827)	$ 3		205,278	(209,108)
Beginning balance (in shares) at Jun. 30, 2023		28,347,920
Beginning balance at Jun. 30, 2023	4,843	$ 3		204,681	(199,841)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock under employee stock purchase plan (in shares)		46,038
Issuance of common stock under employee stock purchase plan	54			54
Stock-based compensation	543			543
Net loss	(9,267)				(9,267)
Ending balance (in shares) at Sep. 30, 2023		28,393,958
Ending balance at Sep. 30, 2023	$ (3,827)	$ 3		205,278	(209,108)
Beginning balance (in shares) at Dec. 31, 2023	32,132,890	32,132,890
Beginning balance at Dec. 31, 2023	$ (7,976)	$ 3		209,265	(217,244)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and common stock warrants, net of issuance costs (in shares)		27,500,070
Issuance of common stock and common stock warrants, net of issuance costs	46,164	$ 3		46,161
Issuance of common stock upon the exercise of pre-funded warrants (in shares)		745,850	3,899,316
Issuance of common stock upon the exercise of pre-funded warrants	559			559
Issuance of common stock under employee stock purchase plan (in shares)		103,853
Issuance of common stock under employee stock purchase plan	98			98
Stock-based compensation	1,191			1,191
Net loss	$ (24,144)				(24,144)
Ending balance (in shares) at Sep. 30, 2024	64,381,979	64,381,979
Ending balance at Sep. 30, 2024	$ 15,892	$ 6		257,274	(241,388)
Beginning balance (in shares) at Jun. 30, 2024		57,754,928
Beginning balance at Jun. 30, 2024	2,913	$ 5		237,188	(234,280)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and common stock warrants, net of issuance costs (in shares)		6,370,070
Issuance of common stock and common stock warrants, net of issuance costs	19,504	$ 1		19,503
Issuance of common stock upon the exercise of pre-funded warrants (in shares)		207,500
Issuance of common stock upon the exercise of pre-funded warrants	155			155
Issuance of common stock under employee stock purchase plan (in shares)		49,481
Issuance of common stock under employee stock purchase plan	47			47
Stock-based compensation	381			381
Net loss	$ (7,108)				(7,108)
Ending balance (in shares) at Sep. 30, 2024	64,381,979	64,381,979
Ending balance at Sep. 30, 2024	$ 15,892	$ 6		$ 257,274	$ (241,388)